PMC Isochem invests 2 Millions € in R&D
PMC Isochem invests 2 Millions € in new R&D capability: New labs, Kilolab and new analytical technology equipment.
This R&D capability expansion will support CDMO and Polyamino acids for Drug delivery business growth.
About PMC Isochem:
PMC Isochem offers Drug Delivery solutions, CDMO services and Active Pharmaceutical Ingredients and intermediates:
- From development to GMP production of Amphiphilic and hydrophilic polymers for pharmaceutical formulations
- Vitamin E based polymers : Vitamin E TPGS NF (Tocophersolan) for poorly soluble drugs and amorphous solid dispersion formulation
- Polyamino acid based biopolymers for nanoencapsulation, polymer drug conjugates and formulation of proteins
- Activated amino acids for polyamino acids synthesis and use in drug delivery
- CDMO services: APIs and news chemical entities, development, clinical supply, commercial GMP manufacturing
- Generic APIs and intermediates
